Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol infusion with versus without lidocaine during ERCP
IRCT20190325043107N33Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pain comparing Propofol + lidocaine with Propofol + normal saline (2 arms). Primary endpoint: Pain. Started May 2023; status: completed.
02
Drugs
propofollidocaine
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20190325043107N33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N33.